Anti-VEGF therapy - A role in obesity-related breast cancer

Abstract

Obesity increases the risk of breast cancer and decreases the survival of patients with breast cancer, particularly for postmenopausal, oestrogen receptor-positive breast cancer. New findings now add to the evidence for the detrimental effects of obesity in patients with breast cancer by showing that obesity can cause resistance to therapy.